|
PNMAL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.731550E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.579800E-02 |
| Normal-vs-Stage2 |
4.814400E-01 |
| Normal-vs-Stage3 |
5.997400E-01 |
| Normal-vs-Stage4 |
6.553200E-01 |
| Stage1-vs-Stage2 |
7.943000E-01 |
| Stage1-vs-Stage3 |
6.408600E-01 |
| Stage1-vs-Stage4 |
2.791000E-01 |
| Stage2-vs-Stage3 |
9.016000E-01 |
| Stage2-vs-Stage4 |
4.058400E-01 |
| Stage3-vs-Stage4 |
5.199600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.582300E-03 |
| Normal-vs-AfricanAmerican |
3.142200E-01 |
| Normal-vs-Asian |
8.567000E-01 |
| Caucasian-vs-AfricanAmerican |
1.657030E-01 |
| Caucasian-vs-Asian |
5.625000E-01 |
| AfricanAmerican-vs-Asian |
8.449800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.102830E-01 |
| Normal-vs-Female |
2.756600E-03 |
| Male-vs-Female |
2.923700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.863000E-01 |
| Normal-vs-Extreme_Weight |
1.225850E-01 |
| Normal-vs-Obese |
2.242200E-02 |
| Normal-vs-Extreme_Obese |
8.298800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.288800E-01 |
| Normal_Weight-vs-Obese |
1.903630E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.574400E-01 |
| Extreme_Weight-vs-Obese |
4.722400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.837800E-01 |
| Obese-vs-Extreme_Obese |
1.900970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.578200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.055600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.300160E-01 |
| Normal-vs-Age(81-100Yrs) |
6.358600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.233600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.287400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.066200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.206200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.140000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.793400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.554880E-04 |
| Normal-VS-Type2 PRCC |
5.245200E-01 |
| Normal-VS-KIRP CIMP |
1.133630E-01 |
| Normal-VS-Unclassified PRCC |
1.538220E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.97107999999613E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.635800E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.299600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.469800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.782200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.221300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.542200E-01 |
| Normal-vs-N1 |
3.413200E-01 |
| Normal-vs-N2 |
4.735000E-01 |
| N0-vs-N1 |
4.099200E-01 |
| N0-vs-N2 |
5.650200E-01 |
| N1-vs-N2 |
4.528600E-01 |
|
|
